E&M 99213 + Injection 96372
Office E&M visit (99213) and therapeutic injection administration (96372) on the same day are bundled by NCCI unless modifier 25 is appended to the E&M.
Why this pair bundles
Per the NCCI Policy Manual, the work of evaluating the patient prior to a minor procedure is included in the procedure global. Reporting both implies the E&M was significant and separately identifiable from the routine pre-procedure assessment.
Modifier-bypass policy
Modifier indicator: 1 — modifier 59 / XE / XP / XS / XU permitted when supporting documentation is on file.
Append modifier 25 to the E&M (99213) when the encounter included a significant, separately identifiable evaluation beyond what's normally bundled into the 96372 pre-service work.
Documentation requirements
- Documented separate complaint or condition addressed at the E&M (different from the reason for the injection)
- Distinct HPI, exam, and MDM elements for the E&M
- Note that explicitly addresses two distinct clinical issues
Common clinical scenarios
- Patient presents for B12 injection AND complains of new joint pain — E&M for joint pain + 96372 for B12
- Established patient receives scheduled testosterone injection PLUS provider evaluates BP changes
- Vitamin D injection during a wellness visit that includes other E&M decisions
Frequently asked questions
Why does CMS bundle 99213 and 96372?
Per the NCCI Policy Manual, the work of evaluating the patient prior to a minor procedure is included in the procedure global. Reporting both implies the E&M was significant and separately identifiable from the routine pre-procedure assessment.
When can I use modifier 59 (or X{EPSU}) to bypass?
Append modifier 25 to the E&M (99213) when the encounter included a significant, separately identifiable evaluation beyond what's normally bundled into the 96372 pre-service work.
What documentation supports separate billing?
Documented separate complaint or condition addressed at the E&M (different from the reason for the injection); Distinct HPI, exam, and MDM elements for the E&M; Note that explicitly addresses two distinct clinical issues.
When does this conflict typically arise?
Patient presents for B12 injection AND complains of new joint pain — E&M for joint pain + 96372 for B12; Established patient receives scheduled testosterone injection PLUS provider evaluates BP changes; Vitamin D injection during a wellness visit that includes other E&M decisions.
Related NCCI edits
- E&M 99213 + RPM treatment management (0780T equivalent)Remote physiologic monitoring services and same-day E&M generally do NOT bundle
- E&M 99213 + Joint injection 20610E&M and major joint injection (knee, shoulder, hip) bundle without modifier 25 o
- E&M 99213 + Venipuncture 36415Office E&M and routine venipuncture can be reported together — 36415 is separate
- E&M 99213 + Urine pregnancy test 81025Urine pregnancy test (POC) and office E&M can be reported together — 81025 is se
- E&M 99213 + Vaccine admin 90471E&M 99213 and vaccine administration 90471 bundle without modifier 25 on the E&M
- E&M 99213 + ECG 93000Office E&M and complete ECG can be reported together but require modifier 25 on
Sources
Catch NCCI 99213/96372 conflicts before submission
ApprovalHelp auto-flags NCCI bundling conflicts on the claim line before you submit. Modifier-bypass eligibility checked against current quarterly NCCI tables. no setup fee.
Get started →Contact: hello@approvalhelp.com